Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis
Two grade 5 toxicities (febrile neutropenia and anemia) occurred in CRT group.
»
04/03/18
Radiotherapy-induced cell death activates paracrine HMGB1-TLR2 signaling and accelerates pancreatic carcinoma metastasis
Dying pancreatic cancer cells significantly promote cancer metastasis in vivo.
»
04/03/18
Role of serum response factor expression in prostate cancer biochemical recurrence.
Combination of SRF and T stage had higher AUC value than the two taken separately.
»
01/15/18
Spread Through Air Spaces is a Prognostic Factor in Sublobar Resection of Non-Small Cell Lung Cancer.
Patients with STAS and sublobar resection had significantly higher rate of pulmonary metastases.
»
01/04/18
ERBB4 promotes the proliferation of gastric cancer cells via the PI3K/Akt signaling pathway.
Inhibition of expression of ERBB4 could inhibit activation of PI3K/Akt signaling pathway.
»
10/21/17
Effective Delivery of Arsenic Trioxide to HPV-Positive Cervical Cancer Cells Using Optimised Liposomes: A Size and Charge Study.
Optimised formulation of liposomes was effective drug delivery method.
»
02/20/18
LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway.
Overexpression of TP73-AS1 diminished epithelial-mesenchymal transition (EMT).
»
03/31/18
Glucocorticoid receptor overexpression slightly shifts microRNA expression patterns in triple-negative breast cancer.
Mmolecular mechanisms responsible for oncogenic effects of GR on TNBC have yet to be fully elucidated.
»
12/15/17
Adoptive immunotherapy using PRAME-specific T cells in medulloblastoma.
T cells genetically modified with high-affinity, PRAME-specific TCR and iC9 may be innovative approach for treating HLA-A*02+ medulloblastoma patients.
»
03/30/18
Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study.
SEPT9 ccfDNA methylation further allowed for accurate pre- and post-therapeutic detection of distant metastases.
»
10/16/17
< Prev
Next >